Literature DB >> 3996312

Some chemical properties of human erythropoietin.

F F Wang, C K Kung, E Goldwasser.   

Abstract

Erythropoietin (epo) is the glycoprotein hormone that induces normal red cell differentiation. Reaction of native or denatured epo with either [3H]iodoacetic acid or N-ethyl-2-[3H]maleimide did not result in the incorporation of any significant amount of radioactivity. Radiolabeling took place only if the protein were denatured before reduction and alkylation. When reduction was carried out in the presence of 6 M guanidine HCl, about 3.7 mol N-ethyl-2[3H]maleimide were covalently linked per mol epo. These results show that there are no free, accessible sulfhydryl groups in epo; there are two internal disulfide bonds. When epo was reduced in the presence of 6 M guanidine HCl and then reoxidized and the guanidine removed, about 85% of the biological activity was regenerated. The biological activity was lost irreversibly if the sulfhydryl groups were alkylated. Limited proteolysis of [3H]epo (labeled at sialic acid residues of the oligosaccharide chains) showed that it consists of two rather trypsin-resistant domains, each having a mol wt of about 16,000, connected by a small region of protein that is trypsin sensitive. The two large fragments contain most of the label. Biological activity and immunoreactivity are lost after limited tryptic proteolysis. Complexing epo with a neutralizing antibody protects its activity from proteolysis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3996312     DOI: 10.1210/endo-116-6-2286

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  12 in total

1.  German Physiology Society. Abstracts of the Spring Meeting (69th Meeting). 5-8 March 1991, Freiburg.

Authors: 
Journal:  Pflugers Arch       Date:  1991       Impact factor: 3.657

2.  Cloning, sequencing, and evolutionary analysis of the mouse erythropoietin gene.

Authors:  J D McDonald; F K Lin; E Goldwasser
Journal:  Mol Cell Biol       Date:  1986-03       Impact factor: 4.272

Review 3.  Erythropoietin and diabetes mellitus.

Authors:  Kenneth Maiese
Journal:  World J Diabetes       Date:  2015-10-25

Review 4.  Erythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life Expectancy.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2016       Impact factor: 1.990

5.  Development of an in vitro Bioassay for Recombinant Human Erythropoietin (rHuEPO) Based on Proliferative Stimulation of an Erythroid Cell Line and Analysis of Sialic Acid Dependent Microheterogeneity: UT-7 Cell Bioassay.

Authors:  Manoj Kumar Metta; Vasavi Malkhed; Srinivasan Tantravahi; Uma Vuruputuri; Rajkumar Kunaparaju
Journal:  Protein J       Date:  2017-04       Impact factor: 2.371

6.  Homology modeling of the receptor binding domain of human thrombopoietin.

Authors:  J S Song; H Park; H J Hong; M H Yu; S E Ryu
Journal:  J Comput Aided Mol Des       Date:  1998-09       Impact factor: 3.686

Review 7.  Erythropoietin and oxidative stress.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Jinling Hou; Yan Chen Shang
Journal:  Curr Neurovasc Res       Date:  2008-05       Impact factor: 1.990

8.  Murine erythropoietin gene: cloning, expression, and human gene homology.

Authors:  C B Shoemaker; L D Mitsock
Journal:  Mol Cell Biol       Date:  1986-03       Impact factor: 4.272

Review 9.  Erythropoietin: elucidating new cellular targets that broaden therapeutic strategies.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Faqi Li; Yan Chen Shang
Journal:  Prog Neurobiol       Date:  2008-03-04       Impact factor: 11.685

10.  Regeneration in the nervous system with erythropoietin.

Authors:  Kenneth Maiese
Journal:  Front Biosci (Landmark Ed)       Date:  2016-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.